| 1 |
Rijkse E, de Jonge J, Kimenai H, et al. Safety and feasibility of 2 h of normothermic machine perfusion of donor kidneys in the Eurotransplant Senior Program[J]. BJS Open, 2021，5(1): zraa024.
|
| 2 |
Hameed AM, Lu DB, Patrick E, et al. Brief normothermic machine perfusion rejuvenates discarded human kidneys[J]. Transplant Direct, 2019，5(11)：e502.
|
| 3 |
Gasteiger S, Berchtold V, Bösmüller C, et al. A retrospective propensity score matched analysis reveals superiority of hypothermic machine perfusion over static cold storage in deceased donor kidney transplantation[J]. J Clin Med, 2020，9(7)：2311.
|
| 4 |
Hosgood SA, Elliott TR, Jordan NP, et al. The effects of free heme on functional and molecular changes during ex vivo normothermic machine perfusion of human kidneys[J]. Front Immunol, 2022，13：849742.
|
| 5 |
Weissenbacher A, Messner F, Gasteiger S, et al. Forty-eight hours of normothermic kidney preservation applying urine recirculation[J]. Artif Organs, 2022，46(4)：710-714.
|
| 6 |
Pool M, Eertman T, Sierra Parraga J, et al. Infusing mesenchymal stromal cells into porcine kidneys during normothermic machine perfusion: intact MSCs can be traced and localised to glomeruli[J]. Int J Mol Sci, 2019，20(14)：3607.
|
| 7 |
Hameed AM, Lu DB, Burns H, et al. Pharmacologic targeting of renal ischemia-reperfusion injury using a normothermic machine perfusion platform[J]. Sci Rep, 2020，10(1)：6930.
|
| 8 |
Aburawi MM, Fontan FM, Karimian N, et al. Synthetic hemoglobin-based oxygen carriers are an acceptable alternative for packed red blood cells in normothermic kidney perfusion[J]. Am J Transplant, 2019，19(10)：2814-2824.
|
| 9 |
Hameed AM, Miraziz R, Lu DB, et al. Extra-corporeal normothermic machine perfusion of the porcine kidney: working towards future utilization in Australasia[J]. ANZ J Surg, 2018，88(5)：E429-E434.
|
| 10 |
Hosgood SA, Saeb-Parsy K, Wilson C, et al. Protocol of a randomised controlled, open-label trial of ex vivo normothermic perfusion versus static cold storage in donation after circulatory death renal transplantation[J]. BMJ Open, 2017，7(1)：e012237.
|
| 11 |
Adams TD, Patel M, Hosgood SA, et al. Lowering perfusate temperature from 37 ℃ to 32 ℃ diminishes function in a porcine model of ex vivo kidney perfusion[J]. Transplant Direct, 2017，3(3)：e140.
|
| 12 |
Minor T, von Horn C, Gallinat A, et al. First-in-man controlled rewarming and normothermic perfusion with cell-free solution of a kidney prior to transplantation[J]. Am J Transplant, 2020，20(4)：1192-1195.
|
| 13 |
Hosgood SA, Thompson E, Moore T, et al. Normothermic machine perfusion for the assessment and transplantation of declined human kidneys from donation after circulatory death donors[J]. Br J Surg, 2018，105(4)：388-394.
|
| 14 |
Hosgood SA, Hoff M, Nicholson ML. Treatment of transplant kidneys during machine perfusion[J]. Transpl Int, 2021，34(2)：224-232.
|
| 15 |
Hamar M, Urbanellis P, Kaths MJ, et al. Normothermic ex vivo kidney perfusion reduces warm ischemic injury of porcine kidney grafts retrieved after circulatory death[J]. Transplantation, 2018，102(8)：1262-1270.
|
| 16 |
Hosgood SA, Nicholson ML. An assessment of urinary biomarkers in a series of declined human kidneys measured during ex vivo normothermic kidney perfusion[J]. Transplantation, 2017，101(9)：2120-2125.
|
| 17 |
Hosgood SA, Brown RJ, Nicholson ML. Advances in kidney preservation techniques and their application in clinical practice[J]. Transplantation, 2021，105(11)：e202-e214.
|
| 18 |
Tennankore KK, Kim SJ, Alwayn IP, et al. Prolonged warm ischemia time is associated with graft failure and mortality after kidney transplantation[J]. Kidney Int, 2016，89(3)：648-658.
|